[Results of chemotherapy in tuberculosis].
D000553:Ambulatory Care; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004357:Drug Synergism; D004977:Ethambutol / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014401:Tuberculosis, Urogenital / Q000188:drug therapy; D014756:Viomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D010455:Peptides; D011718:Pyrazinamide; D004977:Ethambutol; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D014756:Viomycin
Bilanz der Chemotherapie der Tuberkulose.